The  	The  	 DT	O
food  	food  	 NN	O
born  	born  	 VBN	O
mycotoxin  	mycotoxin  	 JJ	B-NP
deoxynivalenol  	deoxynivalenol  	 NN	I-NP
induces  	induces  	 VBZ	O
low-grade  	low-grade  	 JJ	B-NP
inflammation  	inflammation  	 NN	I-NP
in  	in  	 IN	O
mice  	mice  	 NNS	O
in  	in  	 IN	O
the  	the  	 DT	O
absence  	absence  	 NN	B-NP
of  	of  	 IN	I-NP
observed-adverse  	observed-adverse  	 JJ	I-NP
effects  	effects  	 NNS	I-NP
Deoxynivalenol  	Deoxynivalenol  	 NNP	I-NP
( 	( 	 -LRB-	O
DON 	DON 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
fungi  	fungi  	 JJ	B-NP
toxin  	toxin  	 NN	I-NP
contaminating  	contaminating  	 NN	I-NP
cereals  	cereals  	 NNS	I-NP
and  	and  	 CC	O
cereal-derived  	cereal-derived  	 JJ	O
products 	products 	 NNS	O
.  	.  	 .	O
High  	High  	 JJ	B-NP
consumption  	consumption  	 NN	I-NP
of  	of  	 IN	O
DON  	DON  	 NNP	O
is  	is  	 VBZ	O
implicated  	implicated  	 VBN	O
in  	in  	 IN	O
mycotoxicoses  	mycotoxicoses  	 NN	B-NP
and  	and  	 CC	O
causes  	causes  	 VBZ	O
a  	a  	 DT	O
set  	set  	 NN	O
of  	of  	 IN	O
symptoms  	symptoms  	 NNS	B-NP
including  	including  	 VBG	I-NP
diarrhea 	diarrhea 	 NN	I-NP
,  	,  	 ,	O
vomiting 	vomiting 	 NN	O
,  	,  	 ,	O
reduced  	reduced  	 VBN	B-NP
weight  	weight  	 NN	I-NP
gain  	gain  	 NN	I-NP
or  	or  	 CC	O
immunologic  	immunologic  	 JJ	B-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
such  	such  	 JJ	O
clinical  	clinical  	 JJ	B-NP
intoxications  	intoxications  	 NNS	I-NP
are  	are  	 VBP	O
rare  	rare  	 JJ	O
in  	in  	 IN	O
humans 	humans 	 NNS	O
,  	,  	 ,	O
who  	who  	 WP	O
are  	are  	 VBP	O
most  	most  	 RBS	O
frequently 	frequently 	 RB	O
,  	,  	 ,	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
low  	low  	 JJ	O
DON  	DON  	 NN	O
doses  	doses  	 NNS	O
without  	without  	 IN	O
developing  	developing  	 VBG	O
acute  	acute  	 JJ	O
symptoms 	symptoms 	 NNS	B-NP
.  	.  	 .	O
The  	The  	 DT	O
adverse  	adverse  	 JJ	O
effect  	effect  	 NN	O
of  	of  	 IN	O
chronically  	chronically  	 RB	O
consumed  	consumed  	 VBN	O
low  	low  	 JJ	O
DON  	DON  	 NN	O
doses  	doses  	 NNS	O
can  	can  	 MD	O
not  	not  	 RB	O
be  	be  	 VB	O
totally  	totally  	 RB	O
excluded 	excluded 	 VBN	O
.  	.  	 .	O
Using  	Using  	 VBG	O
a  	a  	 DT	O
mouse  	mouse  	 NN	O
model 	model 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
evaluated  	evaluated  	 VBD	O
the  	the  	 DT	O
impact  	impact  	 NN	O
on  	on  	 IN	O
inflammatory  	inflammatory  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	I-NP
subchronic  	subchronic  	 JJ	I-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	O
DON  	DON  	 NNP	O
given  	given  	 VBN	O
at  	at  	 IN	O
doses  	doses  	 JJ	O
comparable  	comparable  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
daily  	daily  	 JJ	O
human  	human  	 JJ	O
consumption 	consumption 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
status  	status  	 NN	I-NP
was  	was  	 VBD	O
evaluated  	evaluated  	 VBN	O
in  	in  	 IN	O
mice  	mice  	 NNS	O
receiving  	receiving  	 VBG	O
1 	1 	 CD	O
,  	,  	 ,	O
2.5  	2.5  	 CD	O
or  	or  	 CC	O
25μg 	25μg 	 CD	O
/ 	/ 	 CD	O
kg  	kg  	 CD	B-NP
bw 	bw 	 CD	I-NP
/ 	/ 	 CD	I-NP
day  	day  	 NN	I-NP
DON  	DON  	 NN	I-NP
during  	during  	 IN	O
a  	a  	 DT	O
10  	10  	 CD	O
or  	or  	 CC	O
30  	30  	 CD	O
days  	days  	 NNS	O
period 	period 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
systemic  	systemic  	 JJ	B-NP
interleukin-1  	interleukin-1  	 CD	I-NP
beta  	beta  	 NN	I-NP
( 	( 	 -LRB-	O
IL-1β 	IL-1β 	 NNP	B-NP
)  	)  	 -RRB-	O
concentrations  	concentrations  	 NNS	B-NP
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
by  	by  	 IN	O
Elisa  	Elisa  	 NNP	O
and  	and  	 CC	O
inflammatory  	inflammatory  	 JJ	B-NP
biomarker  	biomarker  	 JJ	I-NP
mRNA  	mRNA  	 JJ	I-NP
expressions  	expressions  	 NNS	I-NP
were  	were  	 VBD	O
quantified  	quantified  	 VBN	O
by  	by  	 IN	O
qPCR  	qPCR  	 JJ	O
within  	within  	 IN	O
brain  	brain  	 NN	O
structures  	structures  	 NNS	O
and  	and  	 CC	O
peripheral  	peripheral  	 JJ	B-NP
organs 	organs 	 NNS	I-NP
.  	.  	 .	O
While  	While  	 IN	O
DON  	DON  	 NNP	O
intake  	intake  	 VBD	O
failed  	failed  	 VBN	O
to  	to  	 TO	O
modify  	modify  	 VB	O
physiological  	physiological  	 JJ	B-NP
markers 	markers 	 NN	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
observed  	observed  	 VBD	O
a  	a  	 DT	O
systemic  	systemic  	 JJ	B-NP
IL-1β  	IL-1β  	 CD	I-NP
increase  	increase  	 NN	I-NP
and  	and  	 CC	O
a  	a  	 DT	O
modulation  	modulation  	 NN	B-NP
of  	of  	 IN	I-NP
pro-inflammatory  	pro-inflammatory  	 JJ	I-NP
gene  	gene  	 NN	I-NP
expression  	expression  	 NN	I-NP
in  	in  	 IN	O
brain  	brain  	 NN	O
structures 	structures 	 NNS	O
,  	,  	 ,	O
liver 	liver 	 NN	O
,  	,  	 ,	O
duodenum  	duodenum  	 NN	B-NP
and  	and  	 CC	O
adipose  	adipose  	 JJ	O
tissue 	tissue 	 NN	O
.  	.  	 .	O
We  	We  	 PRP	O
bring  	bring  	 VBP	O
here  	here  	 RB	O
the  	the  	 DT	O
first  	first  	 JJ	O
evidence  	evidence  	 NN	O
that  	that  	 IN	O
subchronic  	subchronic  	 FW	B-NP
DON  	DON  	 FW	I-NP
intake 	intake 	 FW	I-NP
,  	,  	 ,	O
at  	at  	 IN	O
doses  	doses  	 NNS	O
that  	that  	 WDT	O
match  	match  	 VBP	O
daily  	daily  	 RB	O
human  	human  	 JJ	O
intake 	intake 	 NN	O
,  	,  	 ,	O
induces 	induces 	 VBZ	O
,  	,  	 ,	O
in  	in  	 IN	O
a  	a  	 DT	O
murine  	murine  	 JJ	B-NP
model 	model 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
central  	central  	 JJ	O
and  	and  	 CC	O
peripheral  	peripheral  	 JJ	B-NP
low  	low  	 JJ	I-NP
grade  	grade  	 NN	I-NP
inflammation 	inflammation 	 NN	I-NP
.  	.  	 .	O
